napharm glp 1 side effects GI Adverse of Glucagon-Like Peptide-1 Receptor Agonists Managing Side Effects of GLP-1

This dynamic produced a largely unregulated online marketplace where telehealth companies and other sellers mass-produced and widely promoted compounded GLP-1 drugs containing a different source of the active pharmaceutical ingredient (what drugs are made from), meaning the compounded versions were not the same and according to the FDA, could contain incorrect doses, too much or too little of the active ingredient, and possibly contaminants and bacteria

Lagan, A

By attaching itself to its receptors and activating adenylate cyclase (AC), which raises cAMP levels in the myocardium, glucagon also increases cardiac output

References: ARS Pharma (2024): Comparative Stability of Three Epinephrine Products Under Extreme Temperature Conditions